Clinical trial · Observational
Iatrogenic Effects of Treatment for Childhood Cancer Constitution of a Biological Samples Bank
Study of Iatrogenic Effects of Treatment for Childhood Cancer - Constitution of a Biological Samples Bank as Part of a Cohort of Patients (Cohort FCCSS)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 11, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260911-000001
Summary
Brief summary (as posted)
The constitution of a biological samples bank, attached to epidemiological studies Cohort F-CCSS on iatrogenic effects of treatment of childhood cancer, will identify genetic variants that can modulate the iatrogenic risks of these treatments. The main objective is to provide a biological samples bank to consider, besides the carcinogenic risks, the risk of other iatrogenic diseases in these children, in particular cardiac, cerebrovascular, lung, bone and kidney. These conditions can be very incapacitating and in some cases, fatal. Their impact, however, is poorly estimated as occurring in adulthood, they are rarely made in relation to the treatment received in childhood. The overall project is expected to eventually better define the iatrogenic effects prevention strategies for cancer treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Paediatric Malignancies | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| blood samples | Procedure | — | UNRESOLVED |
| saliva samples | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients treated for cancer in childhood
- interventionNames
- Procedure: saliva samples
- Procedure: blood samples
Primary outcomes (1)
- measure
- Study of genetic factors who might lead to secondary iatrogenic pathology due to treatment of a childhood cancer
- timeFrame
- From enrollment to the end of study at 15 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients treated for a first cancer in childhood * Adult patients * Signed informed consent * Patient insured or enjoying a social security scheme Exclusion Criteria: * Minor patients * Under legal protection measure patients * Refusal of consent
References
Publications (0)
Data not yet available